Business
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2025 Financial Results
OLDSMAR, Fla., July 15, 2025--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the "Company"), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal second quarter ended May 31, 2025.
About this update from Cryo-cell International, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/29b4b807917b513ebb008b530c51608b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/3JxgIvHpEv.qYuvVsJs3mw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/29b4b807917b513ebb008b530c51608b","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/vZGDw_vUYptwSsftw5qalA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/29b4b807917b513ebb008b530c51608b","width":1024,"height":512}},"lazy":false},{"type":"text","content":"OLDSMAR, Fla., July 15, 2025--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the "Company"), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal second quarter ended May 31, 2025.","length":281,"tagName":"p"},{"type":"text","content":"Financial Results","length":17,"tagName":"p"},{"type":"text","content":"Revenue","length":7,"tagName":"p"},{"type":"text","content":"The revenues for the second quarter of fiscal 2025 were $7.9 million compared to $8.0 million for the second quarter of fiscal 2024, a 1% decrease. The revenues for the second quarter of fiscal 2025 consisted of $7.87 million in processing and storage fee revenue, $43,000 in public banking revenue and $14,000 in product revenue compared to $7.97 million in processing and storage fee revenue, $41,000 in public banking revenue and $36,000 in product revenue for the second quarter of fiscal 2024.","length":498,"tagName":"p"},{"type":"text","content":"Net Income","length":10,"tagName":"p"},{"type":"text","content":"The Company reported net income of $356,000, or $0.04 per basic and diluted common shares for the three months ended May 31, 2025, compared to net income of $656,000, or $0.08 per basic and diluted common shares for the three months ended May 31, 2024.","length":252,"tagName":"p"},{"type":"text","content":"About Cryo-Cell International, Inc.","length":35,"tagName":"p"},{"type":"text","content":"Founded in 1989, Cryo-Cell International, Inc. is the world’s first private cord blood bank. More than 500,000 parents from 87 countries h...